Advertisement
Advertisement
CLPT
ClearPoint Neuro, Inc. Common Stock
13.46
USDSponsored
+0.89
+7.08%
Feb 06, 15:59 UTC -5
Closed
After-Market
13.44
-0.02
-0.15%
CLPT Earnings Reports
Positive Surprise Ratio
CLPT beat 15 of 26 last estimates.
58%
Next Report
Date of Next Report
Mar 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
$10.25M
/-$0.20
Implied change from Q3 25 (Revenue/ EPS)
+15.69%
/-4.76%
Implied change from Q4 24 (Revenue/ EPS)
+31.91%
/--
ClearPoint Neuro, Inc. Common Stock earnings per share and revenue
On Nov 06, 2025, CLPT reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.20 USD, resulting in a -2.94% surprise. Revenue reached 8.86 million, compared to an expected 9.79 million, with a -9.51% difference. The market reacted with a -13.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 10.25 million USD, implying an decrease of -4.76% EPS, and increase of 15.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were ClearPoint Neuro, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ClearPoint Neuro, Inc. Common Stock reported EPS of -$0.21, missing estimates by -2.94%, and revenue of $8.86M, -9.51% below expectations.
How did the market react to ClearPoint Neuro, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -13.27%, changed from $18.23 before the earnings release to $15.81 the day after.
When is ClearPoint Neuro, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 04, 2026.
What are the forecasts for ClearPoint Neuro, Inc. Common Stock's next earnings report?
Based on 4
analysts, ClearPoint Neuro, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $10.25M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement